134 related articles for article (PubMed ID: 1511027)
21. Molecular detection of metastatic pancreatic carcinoma cells using a multimarker reverse transcriptase-polymerase chain reaction assay.
Bilchik A; Miyashiro M; Kelley M; Kuo C; Fujiwara Y; Nakamori S; Monden M; Hoon DS
Cancer; 2000 Mar; 88(5):1037-44. PubMed ID: 10699892
[TBL] [Abstract][Full Text] [Related]
22. Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases.
Schmitt AM; Riniker F; Anlauf M; Schmid S; Soltermann A; Moch H; Heitz PU; Klöppel G; Komminoth P; Perren A
Am J Surg Pathol; 2008 Mar; 32(3):420-5. PubMed ID: 18300808
[TBL] [Abstract][Full Text] [Related]
23. The molecular genetics of pancreatic ductal carcinoma.
Sohn TA
Minerva Chir; 2002 Oct; 57(5):561-74. PubMed ID: 12370658
[TBL] [Abstract][Full Text] [Related]
24. Growth factors and oncogenes in human gastrointestinal carcinomas.
Tahara E
J Cancer Res Clin Oncol; 1990; 116(2):121-31. PubMed ID: 2157713
[TBL] [Abstract][Full Text] [Related]
25. Molecular prognostic markers in pancreatic cancer: a systematic review.
Garcea G; Neal CP; Pattenden CJ; Steward WP; Berry DP
Eur J Cancer; 2005 Oct; 41(15):2213-36. PubMed ID: 16146690
[TBL] [Abstract][Full Text] [Related]
26. Evidence for a new tumor-suppressor gene involved in gastrointestinal malignancies.
Wasylyshyn ML; Neuman WL; Angriman I; Snyder LA; Montag AG; Westbrook CA; Michelassi F
Surgery; 1991 Aug; 110(2):265-8; discussion 268-9. PubMed ID: 1858037
[TBL] [Abstract][Full Text] [Related]
27. Dynamics of circadian fluctuations in serum concentration of cortisol and TNF-alpha soluble receptors in gastrointestinal cancer patients.
Zubelewicz-Szkodzinska B; Muc-Wierzgon M; Wierzgon J; Brodziak A
Oncol Rep; 2001; 8(1):207-12. PubMed ID: 11115600
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of molecular biological and immunohistological parameters in gastrointestinal carcinomas.
Rüschoff J; Bocker T; Vogel P; Schlegel J
Recent Results Cancer Res; 1996; 142():73-88. PubMed ID: 8893336
[TBL] [Abstract][Full Text] [Related]
29. Gastrointestinal cancer-associated antigen in immunoperoxidase assay.
Atkinson BF; Ernst CS; Herlyn M; Steplewski Z; Sears HF; Koprowski H
Cancer Res; 1982 Nov; 42(11):4820-3. PubMed ID: 6751528
[TBL] [Abstract][Full Text] [Related]
30. The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies.
Staab HJ; Brümmendorf T; Hornung A; Anderer FA; Kieninger G
Klin Wochenschr; 1985 Feb; 63(3):106-15. PubMed ID: 3856076
[TBL] [Abstract][Full Text] [Related]
31. Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators.
Ardill JE; O'Dorisio TM
Endocrinol Metab Clin North Am; 2010 Dec; 39(4):777-90. PubMed ID: 21095544
[TBL] [Abstract][Full Text] [Related]
32. Endometrial neoplasia: prognostic significance of ploidy status.
Evans MP; Podratz KC
Clin Obstet Gynecol; 1996 Sep; 39(3):696-706. PubMed ID: 8862893
[TBL] [Abstract][Full Text] [Related]
33. Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.
Gorgoulis VG; Kotsinas A; Zacharatos P; Mariatos G; Liloglou T; Tsoli E; Kokotas S; Fassoulas C; Field JK; Kittas C
Cancer; 2000 Nov; 89(9):1933-45. PubMed ID: 11064350
[TBL] [Abstract][Full Text] [Related]
34. Response to exogenous cholecystokinin of six human gastrointestinal cancers xenografted in nude mice.
Hudd C; LaRegina MC; Devine JE; Palmer DC; Herbold DR; Beinfeld MC; Gelder FB; Johnson FE
Am J Surg; 1989 Apr; 157(4):386-94. PubMed ID: 2467570
[TBL] [Abstract][Full Text] [Related]
35. The diagnostic value of CA 27-29, CA 15-3, mucin-like carcinoma antigen, carcinoembryonic antigen and CA 19-9 in breast and gastrointestinal malignancies.
Frenette PS; Thirlwell MP; Trudeau M; Thomson DM; Joseph L; Shuster JS
Tumour Biol; 1994; 15(5):247-54. PubMed ID: 7991985
[TBL] [Abstract][Full Text] [Related]
36. Peptide hormones as tumor markers in neuroendocrine gastrointestinal tumors.
Eriksson B; Oberg K
Acta Oncol; 1991; 30(4):477-83. PubMed ID: 1854505
[TBL] [Abstract][Full Text] [Related]
37. The role of molecular biology in detection and monitoring of prostate cancer.
Zummerová A; Böhmer D; Fillo J; Danihel L; Repiská V
Cesk Patol; 2010 Oct; 46(4):95-7. PubMed ID: 21309265
[TBL] [Abstract][Full Text] [Related]
38. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray.
Maitra A; Adsay NV; Argani P; Iacobuzio-Donahue C; De Marzo A; Cameron JL; Yeo CJ; Hruban RH
Mod Pathol; 2003 Sep; 16(9):902-12. PubMed ID: 13679454
[TBL] [Abstract][Full Text] [Related]
39. Proteomics in gastrointestinal cancer.
Ebert MP; Yu J; Lordick F; Röcken C
Ann Oncol; 2006 Sep; 17 Suppl 10():x253-8. PubMed ID: 17018734
[No Abstract] [Full Text] [Related]
40. Ductal cancers of the pancreas frequently express markers of gastrointestinal epithelial cells.
Sessa F; Bonato M; Frigerio B; Capella C; Solcia E; Prat M; Bara J; Samloff IM
Gastroenterology; 1990 Jun; 98(6):1655-65. PubMed ID: 1692551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
